nodes	percent_of_prediction	percent_of_DWPC	metapath
Lenalidomide—PTGS2—epilepsy syndrome	0.169	0.54	CbGaD
Lenalidomide—ABCB1—epilepsy syndrome	0.144	0.46	CbGaD
Lenalidomide—ABCB1—Levetiracetam—epilepsy syndrome	0.049	0.208	CbGbCtD
Lenalidomide—ABCB1—Clobazam—epilepsy syndrome	0.034	0.145	CbGbCtD
Lenalidomide—ABCB1—Lamotrigine—epilepsy syndrome	0.0327	0.139	CbGbCtD
Lenalidomide—ABCB1—Carbamazepine—epilepsy syndrome	0.0281	0.12	CbGbCtD
Lenalidomide—ABCB1—Phenytoin—epilepsy syndrome	0.0252	0.107	CbGbCtD
Lenalidomide—ABCB1—Phenobarbital—epilepsy syndrome	0.0225	0.0957	CbGbCtD
Lenalidomide—ABCB1—Midazolam—epilepsy syndrome	0.0222	0.0944	CbGbCtD
Lenalidomide—ABCB1—Diazepam—epilepsy syndrome	0.0213	0.0907	CbGbCtD
Lenalidomide—TNFSF11—skull—epilepsy syndrome	0.0183	0.231	CbGeAlD
Lenalidomide—TNFSF11—forelimb—epilepsy syndrome	0.0176	0.222	CbGeAlD
Lenalidomide—TNFSF11—tongue—epilepsy syndrome	0.00941	0.119	CbGeAlD
Lenalidomide—TNFSF11—head—epilepsy syndrome	0.00228	0.0288	CbGeAlD
Lenalidomide—CDH5—medulla oblongata—epilepsy syndrome	0.00217	0.0274	CbGeAlD
Lenalidomide—CDH5—midbrain—epilepsy syndrome	0.00198	0.025	CbGeAlD
Lenalidomide—CDH5—spinal cord—epilepsy syndrome	0.00193	0.0244	CbGeAlD
Lenalidomide—CRBN—forebrain—epilepsy syndrome	0.00191	0.0241	CbGeAlD
Lenalidomide—CRBN—telencephalon—epilepsy syndrome	0.00175	0.0221	CbGeAlD
Lenalidomide—CDH5—head—epilepsy syndrome	0.00172	0.0217	CbGeAlD
Lenalidomide—CDH5—nervous system—epilepsy syndrome	0.00163	0.0206	CbGeAlD
Lenalidomide—CDH5—central nervous system—epilepsy syndrome	0.00157	0.0198	CbGeAlD
Lenalidomide—CDH5—cerebellum—epilepsy syndrome	0.00153	0.0194	CbGeAlD
Lenalidomide—CRBN—medulla oblongata—epilepsy syndrome	0.00138	0.0174	CbGeAlD
Lenalidomide—CRBN—midbrain—epilepsy syndrome	0.00126	0.0159	CbGeAlD
Lenalidomide—CDH5—brain—epilepsy syndrome	0.00125	0.0157	CbGeAlD
Lenalidomide—Pomalidomide—TNF—epilepsy syndrome	0.00124	0.301	CrCbGaD
Lenalidomide—CRBN—spinal cord—epilepsy syndrome	0.00123	0.0155	CbGeAlD
Lenalidomide—CRBN—head—epilepsy syndrome	0.00109	0.0138	CbGeAlD
Lenalidomide—CRBN—nervous system—epilepsy syndrome	0.00104	0.0131	CbGeAlD
Lenalidomide—CRBN—central nervous system—epilepsy syndrome	0.000997	0.0126	CbGeAlD
Lenalidomide—CRBN—cerebellum—epilepsy syndrome	0.000974	0.0123	CbGeAlD
Lenalidomide—Thalidomide—TNF—epilepsy syndrome	0.000799	0.194	CrCbGaD
Lenalidomide—CRBN—brain—epilepsy syndrome	0.000791	0.00998	CbGeAlD
Lenalidomide—Thalidomide—CYP2C19—epilepsy syndrome	0.00061	0.148	CrCbGaD
Lenalidomide—Pomalidomide—PTGS2—epilepsy syndrome	0.000589	0.143	CrCbGaD
Lenalidomide—PTGS2—forebrain—epilepsy syndrome	0.000519	0.00655	CbGeAlD
Lenalidomide—Pomalidomide—ABCB1—epilepsy syndrome	0.000501	0.122	CrCbGaD
Lenalidomide—PTGS2—telencephalon—epilepsy syndrome	0.000477	0.00602	CbGeAlD
Lenalidomide—Thalidomide—PTGS2—epilepsy syndrome	0.00038	0.0922	CrCbGaD
Lenalidomide—PTGS2—medulla oblongata—epilepsy syndrome	0.000375	0.00473	CbGeAlD
Lenalidomide—PTGS2—midbrain—epilepsy syndrome	0.000343	0.00433	CbGeAlD
Lenalidomide—PTGS2—spinal cord—epilepsy syndrome	0.000335	0.00422	CbGeAlD
Lenalidomide—ABCB1—forebrain—epilepsy syndrome	0.000321	0.00405	CbGeAlD
Lenalidomide—PTGS2—head—epilepsy syndrome	0.000297	0.00375	CbGeAlD
Lenalidomide—ABCB1—telencephalon—epilepsy syndrome	0.000295	0.00373	CbGeAlD
Lenalidomide—PTGS2—nervous system—epilepsy syndrome	0.000282	0.00356	CbGeAlD
Lenalidomide—PTGS2—central nervous system—epilepsy syndrome	0.000271	0.00342	CbGeAlD
Lenalidomide—PTGS2—cerebellum—epilepsy syndrome	0.000265	0.00335	CbGeAlD
Lenalidomide—ABCB1—medulla oblongata—epilepsy syndrome	0.000232	0.00293	CbGeAlD
Lenalidomide—PTGS2—brain—epilepsy syndrome	0.000215	0.00272	CbGeAlD
Lenalidomide—ABCB1—midbrain—epilepsy syndrome	0.000212	0.00268	CbGeAlD
Lenalidomide—ABCB1—spinal cord—epilepsy syndrome	0.000207	0.00261	CbGeAlD
Lenalidomide—ABCB1—head—epilepsy syndrome	0.000184	0.00232	CbGeAlD
Lenalidomide—ABCB1—nervous system—epilepsy syndrome	0.000174	0.0022	CbGeAlD
Lenalidomide—ABCB1—central nervous system—epilepsy syndrome	0.000168	0.00212	CbGeAlD
Lenalidomide—ABCB1—cerebellum—epilepsy syndrome	0.000164	0.00207	CbGeAlD
Lenalidomide—ABCB1—brain—epilepsy syndrome	0.000133	0.00168	CbGeAlD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—COX3—epilepsy syndrome	4.33e-05	0.000522	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—YWHAZ—epilepsy syndrome	4.28e-05	0.000515	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—PDXK—epilepsy syndrome	4.28e-05	0.000515	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—RELA—epilepsy syndrome	4.26e-05	0.000513	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—NGF—epilepsy syndrome	4.23e-05	0.00051	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—epilepsy syndrome	4.14e-05	0.000498	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—SIRT1—epilepsy syndrome	4.12e-05	0.000496	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CCR5—epilepsy syndrome	4.12e-05	0.000496	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—FOS—epilepsy syndrome	4.11e-05	0.000495	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	4.11e-05	0.000495	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	4.11e-05	0.000495	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	4.11e-05	0.000495	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—epilepsy syndrome	4.07e-05	0.00049	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—HTR2A—epilepsy syndrome	4.03e-05	0.000485	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—CCL2—epilepsy syndrome	4.02e-05	0.000483	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—CASP8—epilepsy syndrome	3.92e-05	0.000472	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	3.92e-05	0.000472	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	3.92e-05	0.000472	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—NHLRC1—epilepsy syndrome	3.91e-05	0.000471	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—EPM2A—epilepsy syndrome	3.91e-05	0.000471	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—PNPO—epilepsy syndrome	3.91e-05	0.000471	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—IL1B—epilepsy syndrome	3.85e-05	0.000464	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—TSC2—epilepsy syndrome	3.83e-05	0.000461	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—AGT—epilepsy syndrome	3.82e-05	0.00046	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	3.8e-05	0.000458	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—APOE—epilepsy syndrome	3.75e-05	0.000451	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—KDR—epilepsy syndrome	3.67e-05	0.000442	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—SV2A—epilepsy syndrome	3.64e-05	0.000438	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—epilepsy syndrome	3.63e-05	0.000437	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PDXK—epilepsy syndrome	3.58e-05	0.000431	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ADK—epilepsy syndrome	3.58e-05	0.000431	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—FAR1—epilepsy syndrome	3.58e-05	0.000431	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—L2HGDH—epilepsy syndrome	3.58e-05	0.000431	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GLUD1—epilepsy syndrome	3.58e-05	0.000431	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CERS1—epilepsy syndrome	3.58e-05	0.000431	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—PRKCB—epilepsy syndrome	3.53e-05	0.000425	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—IL6ST—epilepsy syndrome	3.52e-05	0.000424	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CA13—epilepsy syndrome	3.35e-05	0.000403	CbGpPWpGaD
Lenalidomide—ABCB1—HIF-1-alpha transcription factor network—JUN—epilepsy syndrome	3.33e-05	0.000401	CbGpPWpGaD
Lenalidomide—Diarrhoea—Clonazepam—epilepsy syndrome	3.33e-05	0.000117	CcSEcCtD
Lenalidomide—Anaemia—Gabapentin—epilepsy syndrome	3.32e-05	0.000117	CcSEcCtD
Lenalidomide—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	3.32e-05	0.000116	CcSEcCtD
Lenalidomide—Hypotension—Valproic Acid—epilepsy syndrome	3.31e-05	0.000116	CcSEcCtD
Lenalidomide—Asthenia—Carbamazepine—epilepsy syndrome	3.31e-05	0.000116	CcSEcCtD
Lenalidomide—Agitation—Gabapentin—epilepsy syndrome	3.3e-05	0.000116	CcSEcCtD
Lenalidomide—Diarrhoea—Phenytoin—epilepsy syndrome	3.3e-05	0.000116	CcSEcCtD
Lenalidomide—Discomfort—Pregabalin—epilepsy syndrome	3.3e-05	0.000116	CcSEcCtD
Lenalidomide—Nausea—Fosphenytoin—epilepsy syndrome	3.3e-05	0.000116	CcSEcCtD
Lenalidomide—Diarrhoea—Oxcarbazepine—epilepsy syndrome	3.29e-05	0.000115	CcSEcCtD
Lenalidomide—Erythema multiforme—Topiramate—epilepsy syndrome	3.29e-05	0.000115	CcSEcCtD
Lenalidomide—Angioedema—Gabapentin—epilepsy syndrome	3.29e-05	0.000115	CcSEcCtD
Lenalidomide—Hypersensitivity—Lamotrigine—epilepsy syndrome	3.28e-05	0.000115	CcSEcCtD
Lenalidomide—Vomiting—Felbamate—epilepsy syndrome	3.28e-05	0.000115	CcSEcCtD
Lenalidomide—PTGS2—Metabolism—EPM2A—epilepsy syndrome	3.28e-05	0.000394	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—NHLRC1—epilepsy syndrome	3.28e-05	0.000394	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PNPO—epilepsy syndrome	3.28e-05	0.000394	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GAMT—epilepsy syndrome	3.28e-05	0.000394	CbGpPWpGaD
Lenalidomide—Dry mouth—Pregabalin—epilepsy syndrome	3.26e-05	0.000114	CcSEcCtD
Lenalidomide—Pruritus—Carbamazepine—epilepsy syndrome	3.26e-05	0.000114	CcSEcCtD
Lenalidomide—Rash—Felbamate—epilepsy syndrome	3.25e-05	0.000114	CcSEcCtD
Lenalidomide—Eye disorder—Topiramate—epilepsy syndrome	3.25e-05	0.000114	CcSEcCtD
Lenalidomide—Dermatitis—Felbamate—epilepsy syndrome	3.25e-05	0.000114	CcSEcCtD
Lenalidomide—Malaise—Gabapentin—epilepsy syndrome	3.24e-05	0.000114	CcSEcCtD
Lenalidomide—PTGS2—Disease—PFKL—epilepsy syndrome	3.24e-05	0.00039	CbGpPWpGaD
Lenalidomide—Tinnitus—Topiramate—epilepsy syndrome	3.24e-05	0.000114	CcSEcCtD
Lenalidomide—Vertigo—Gabapentin—epilepsy syndrome	3.23e-05	0.000113	CcSEcCtD
Lenalidomide—Headache—Felbamate—epilepsy syndrome	3.23e-05	0.000113	CcSEcCtD
Lenalidomide—Confusional state—Pregabalin—epilepsy syndrome	3.23e-05	0.000113	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	3.22e-05	0.000113	CcSEcCtD
Lenalidomide—Flushing—Topiramate—epilepsy syndrome	3.22e-05	0.000113	CcSEcCtD
Lenalidomide—Cardiac disorder—Topiramate—epilepsy syndrome	3.22e-05	0.000113	CcSEcCtD
Lenalidomide—Syncope—Gabapentin—epilepsy syndrome	3.22e-05	0.000113	CcSEcCtD
Lenalidomide—Leukopenia—Gabapentin—epilepsy syndrome	3.22e-05	0.000113	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—POMC—epilepsy syndrome	3.22e-05	0.000387	CbGpPWpGaD
Lenalidomide—Dizziness—Clonazepam—epilepsy syndrome	3.21e-05	0.000113	CcSEcCtD
Lenalidomide—Nausea—Vigabatrin—epilepsy syndrome	3.21e-05	0.000113	CcSEcCtD
Lenalidomide—Vomiting—Zonisamide—epilepsy syndrome	3.21e-05	0.000112	CcSEcCtD
Lenalidomide—Insomnia—Valproic Acid—epilepsy syndrome	3.2e-05	0.000112	CcSEcCtD
Lenalidomide—Oedema—Pregabalin—epilepsy syndrome	3.2e-05	0.000112	CcSEcCtD
Lenalidomide—Asthenia—Lamotrigine—epilepsy syndrome	3.2e-05	0.000112	CcSEcCtD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—APOD—epilepsy syndrome	3.19e-05	0.000385	CbGpPWpGaD
Lenalidomide—Dizziness—Phenytoin—epilepsy syndrome	3.19e-05	0.000112	CcSEcCtD
Lenalidomide—Rash—Zonisamide—epilepsy syndrome	3.18e-05	0.000112	CcSEcCtD
Lenalidomide—Infection—Pregabalin—epilepsy syndrome	3.18e-05	0.000111	CcSEcCtD
Lenalidomide—Paraesthesia—Valproic Acid—epilepsy syndrome	3.18e-05	0.000111	CcSEcCtD
Lenalidomide—Palpitations—Gabapentin—epilepsy syndrome	3.18e-05	0.000111	CcSEcCtD
Lenalidomide—Dermatitis—Zonisamide—epilepsy syndrome	3.18e-05	0.000111	CcSEcCtD
Lenalidomide—Dizziness—Oxcarbazepine—epilepsy syndrome	3.18e-05	0.000111	CcSEcCtD
Lenalidomide—Nausea—Diazepam—epilepsy syndrome	3.16e-05	0.000111	CcSEcCtD
Lenalidomide—Loss of consciousness—Gabapentin—epilepsy syndrome	3.16e-05	0.000111	CcSEcCtD
Lenalidomide—Headache—Zonisamide—epilepsy syndrome	3.16e-05	0.000111	CcSEcCtD
Lenalidomide—Dyspnoea—Valproic Acid—epilepsy syndrome	3.16e-05	0.000111	CcSEcCtD
Lenalidomide—Diarrhoea—Carbamazepine—epilepsy syndrome	3.15e-05	0.000111	CcSEcCtD
Lenalidomide—Angiopathy—Topiramate—epilepsy syndrome	3.15e-05	0.000111	CcSEcCtD
Lenalidomide—Pruritus—Lamotrigine—epilepsy syndrome	3.15e-05	0.000111	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—CCL2—epilepsy syndrome	3.15e-05	0.000379	CbGpPWpGaD
Lenalidomide—Shock—Pregabalin—epilepsy syndrome	3.15e-05	0.00011	CcSEcCtD
Lenalidomide—Somnolence—Valproic Acid—epilepsy syndrome	3.15e-05	0.00011	CcSEcCtD
Lenalidomide—Immune system disorder—Topiramate—epilepsy syndrome	3.14e-05	0.00011	CcSEcCtD
Lenalidomide—Nervous system disorder—Pregabalin—epilepsy syndrome	3.14e-05	0.00011	CcSEcCtD
Lenalidomide—Cough—Gabapentin—epilepsy syndrome	3.14e-05	0.00011	CcSEcCtD
Lenalidomide—Thrombocytopenia—Pregabalin—epilepsy syndrome	3.13e-05	0.00011	CcSEcCtD
Lenalidomide—Mediastinal disorder—Topiramate—epilepsy syndrome	3.13e-05	0.00011	CcSEcCtD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	3.13e-05	0.000377	CbGpPWpGaD
Lenalidomide—Tachycardia—Pregabalin—epilepsy syndrome	3.12e-05	0.00011	CcSEcCtD
Lenalidomide—Chills—Topiramate—epilepsy syndrome	3.12e-05	0.000109	CcSEcCtD
Lenalidomide—Dyspepsia—Valproic Acid—epilepsy syndrome	3.12e-05	0.000109	CcSEcCtD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	3.11e-05	0.000375	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	3.11e-05	0.000375	CbGpPWpGaD
Lenalidomide—Skin disorder—Pregabalin—epilepsy syndrome	3.11e-05	0.000109	CcSEcCtD
Lenalidomide—Hypertension—Gabapentin—epilepsy syndrome	3.1e-05	0.000109	CcSEcCtD
Lenalidomide—Hyperhidrosis—Pregabalin—epilepsy syndrome	3.09e-05	0.000108	CcSEcCtD
Lenalidomide—Vomiting—Clonazepam—epilepsy syndrome	3.09e-05	0.000108	CcSEcCtD
Lenalidomide—Decreased appetite—Valproic Acid—epilepsy syndrome	3.08e-05	0.000108	CcSEcCtD
Lenalidomide—Alopecia—Topiramate—epilepsy syndrome	3.07e-05	0.000108	CcSEcCtD
Lenalidomide—Vomiting—Phenytoin—epilepsy syndrome	3.07e-05	0.000108	CcSEcCtD
Lenalidomide—Rash—Clonazepam—epilepsy syndrome	3.06e-05	0.000107	CcSEcCtD
Lenalidomide—Dermatitis—Clonazepam—epilepsy syndrome	3.06e-05	0.000107	CcSEcCtD
Lenalidomide—Myalgia—Gabapentin—epilepsy syndrome	3.06e-05	0.000107	CcSEcCtD
Lenalidomide—Chest pain—Gabapentin—epilepsy syndrome	3.06e-05	0.000107	CcSEcCtD
Lenalidomide—Arthralgia—Gabapentin—epilepsy syndrome	3.06e-05	0.000107	CcSEcCtD
Lenalidomide—Nausea—Felbamate—epilepsy syndrome	3.06e-05	0.000107	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	3.06e-05	0.000107	CcSEcCtD
Lenalidomide—Vomiting—Oxcarbazepine—epilepsy syndrome	3.05e-05	0.000107	CcSEcCtD
Lenalidomide—Fatigue—Valproic Acid—epilepsy syndrome	3.05e-05	0.000107	CcSEcCtD
Lenalidomide—Anxiety—Gabapentin—epilepsy syndrome	3.05e-05	0.000107	CcSEcCtD
Lenalidomide—Anorexia—Pregabalin—epilepsy syndrome	3.05e-05	0.000107	CcSEcCtD
Lenalidomide—Dizziness—Carbamazepine—epilepsy syndrome	3.05e-05	0.000107	CcSEcCtD
Lenalidomide—Diarrhoea—Lamotrigine—epilepsy syndrome	3.05e-05	0.000107	CcSEcCtD
Lenalidomide—PTGS2—Spinal Cord Injury—IL1B—epilepsy syndrome	3.05e-05	0.000367	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CA4—epilepsy syndrome	3.05e-05	0.000367	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—QDPR—epilepsy syndrome	3.05e-05	0.000367	CbGpPWpGaD
Lenalidomide—Headache—Clonazepam—epilepsy syndrome	3.05e-05	0.000107	CcSEcCtD
Lenalidomide—Rash—Phenytoin—epilepsy syndrome	3.04e-05	0.000107	CcSEcCtD
Lenalidomide—Mental disorder—Topiramate—epilepsy syndrome	3.04e-05	0.000107	CcSEcCtD
Lenalidomide—Dermatitis—Phenytoin—epilepsy syndrome	3.04e-05	0.000107	CcSEcCtD
Lenalidomide—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	3.04e-05	0.000107	CcSEcCtD
Lenalidomide—PTGS2—Spinal Cord Injury—CASP3—epilepsy syndrome	3.04e-05	0.000366	CbGpPWpGaD
Lenalidomide—Rash—Oxcarbazepine—epilepsy syndrome	3.03e-05	0.000106	CcSEcCtD
Lenalidomide—Pain—Valproic Acid—epilepsy syndrome	3.03e-05	0.000106	CcSEcCtD
Lenalidomide—Constipation—Valproic Acid—epilepsy syndrome	3.03e-05	0.000106	CcSEcCtD
Lenalidomide—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.03e-05	0.000106	CcSEcCtD
Lenalidomide—Headache—Phenytoin—epilepsy syndrome	3.02e-05	0.000106	CcSEcCtD
Lenalidomide—Erythema—Topiramate—epilepsy syndrome	3.02e-05	0.000106	CcSEcCtD
Lenalidomide—Malnutrition—Topiramate—epilepsy syndrome	3.02e-05	0.000106	CcSEcCtD
Lenalidomide—Discomfort—Gabapentin—epilepsy syndrome	3.02e-05	0.000106	CcSEcCtD
Lenalidomide—Headache—Oxcarbazepine—epilepsy syndrome	3.01e-05	0.000106	CcSEcCtD
Lenalidomide—Nausea—Zonisamide—epilepsy syndrome	3e-05	0.000105	CcSEcCtD
Lenalidomide—Dry mouth—Gabapentin—epilepsy syndrome	2.99e-05	0.000105	CcSEcCtD
Lenalidomide—Hypotension—Pregabalin—epilepsy syndrome	2.99e-05	0.000105	CcSEcCtD
Lenalidomide—Flatulence—Topiramate—epilepsy syndrome	2.98e-05	0.000105	CcSEcCtD
Lenalidomide—ABCB1—Allograft Rejection—IL1B—epilepsy syndrome	2.98e-05	0.000358	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	2.97e-05	0.000358	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—CASP3—epilepsy syndrome	2.97e-05	0.000357	CbGpPWpGaD
Lenalidomide—Tension—Topiramate—epilepsy syndrome	2.97e-05	0.000104	CcSEcCtD
Lenalidomide—PTGS2—Disease—STX1B—epilepsy syndrome	2.96e-05	0.000357	CbGpPWpGaD
Lenalidomide—Dysgeusia—Topiramate—epilepsy syndrome	2.96e-05	0.000104	CcSEcCtD
Lenalidomide—Confusional state—Gabapentin—epilepsy syndrome	2.96e-05	0.000104	CcSEcCtD
Lenalidomide—Dizziness—Lamotrigine—epilepsy syndrome	2.95e-05	0.000103	CcSEcCtD
Lenalidomide—Nervousness—Topiramate—epilepsy syndrome	2.94e-05	0.000103	CcSEcCtD
Lenalidomide—Oedema—Gabapentin—epilepsy syndrome	2.93e-05	0.000103	CcSEcCtD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—epilepsy syndrome	2.93e-05	0.000353	CbGpPWpGaD
Lenalidomide—Vomiting—Carbamazepine—epilepsy syndrome	2.93e-05	0.000103	CcSEcCtD
Lenalidomide—Back pain—Topiramate—epilepsy syndrome	2.93e-05	0.000103	CcSEcCtD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—epilepsy syndrome	2.92e-05	0.000352	CbGpPWpGaD
Lenalidomide—Feeling abnormal—Valproic Acid—epilepsy syndrome	2.92e-05	0.000102	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	2.92e-05	0.000102	CcSEcCtD
Lenalidomide—Infection—Gabapentin—epilepsy syndrome	2.92e-05	0.000102	CcSEcCtD
Lenalidomide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—epilepsy syndrome	2.91e-05	0.00035	CbGpPWpGaD
Lenalidomide—Muscle spasms—Topiramate—epilepsy syndrome	2.91e-05	0.000102	CcSEcCtD
Lenalidomide—Rash—Carbamazepine—epilepsy syndrome	2.91e-05	0.000102	CcSEcCtD
Lenalidomide—Dermatitis—Carbamazepine—epilepsy syndrome	2.9e-05	0.000102	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	2.89e-05	0.000102	CcSEcCtD
Lenalidomide—Insomnia—Pregabalin—epilepsy syndrome	2.89e-05	0.000101	CcSEcCtD
Lenalidomide—Nausea—Clonazepam—epilepsy syndrome	2.89e-05	0.000101	CcSEcCtD
Lenalidomide—Headache—Carbamazepine—epilepsy syndrome	2.89e-05	0.000101	CcSEcCtD
Lenalidomide—Shock—Gabapentin—epilepsy syndrome	2.89e-05	0.000101	CcSEcCtD
Lenalidomide—Nervous system disorder—Gabapentin—epilepsy syndrome	2.88e-05	0.000101	CcSEcCtD
Lenalidomide—Paraesthesia—Pregabalin—epilepsy syndrome	2.87e-05	0.000101	CcSEcCtD
Lenalidomide—Thrombocytopenia—Gabapentin—epilepsy syndrome	2.87e-05	0.000101	CcSEcCtD
Lenalidomide—PTGS2—Spinal Cord Injury—MMP9—epilepsy syndrome	2.87e-05	0.000346	CbGpPWpGaD
Lenalidomide—Nausea—Phenytoin—epilepsy syndrome	2.87e-05	0.000101	CcSEcCtD
Lenalidomide—Tachycardia—Gabapentin—epilepsy syndrome	2.86e-05	0.0001	CcSEcCtD
Lenalidomide—PTGS2—Metabolism—COX3—epilepsy syndrome	2.86e-05	0.000345	CbGpPWpGaD
Lenalidomide—Dyspnoea—Pregabalin—epilepsy syndrome	2.85e-05	0.0001	CcSEcCtD
Lenalidomide—Nausea—Oxcarbazepine—epilepsy syndrome	2.85e-05	0.0001	CcSEcCtD
Lenalidomide—Vision blurred—Topiramate—epilepsy syndrome	2.85e-05	0.0001	CcSEcCtD
Lenalidomide—Skin disorder—Gabapentin—epilepsy syndrome	2.85e-05	9.99e-05	CcSEcCtD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	2.85e-05	0.000343	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	2.85e-05	0.000343	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	2.85e-05	0.000343	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	2.85e-05	0.000343	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—FGF2—epilepsy syndrome	2.85e-05	0.000343	CbGpPWpGaD
Lenalidomide—Somnolence—Pregabalin—epilepsy syndrome	2.84e-05	9.98e-05	CcSEcCtD
Lenalidomide—Hyperhidrosis—Gabapentin—epilepsy syndrome	2.84e-05	9.95e-05	CcSEcCtD
Lenalidomide—Tremor—Topiramate—epilepsy syndrome	2.83e-05	9.94e-05	CcSEcCtD
Lenalidomide—Vomiting—Lamotrigine—epilepsy syndrome	2.83e-05	9.93e-05	CcSEcCtD
Lenalidomide—Urticaria—Valproic Acid—epilepsy syndrome	2.81e-05	9.86e-05	CcSEcCtD
Lenalidomide—Rash—Lamotrigine—epilepsy syndrome	2.81e-05	9.85e-05	CcSEcCtD
Lenalidomide—Ill-defined disorder—Topiramate—epilepsy syndrome	2.81e-05	9.84e-05	CcSEcCtD
Lenalidomide—Dermatitis—Lamotrigine—epilepsy syndrome	2.81e-05	9.84e-05	CcSEcCtD
Lenalidomide—Abdominal pain—Valproic Acid—epilepsy syndrome	2.8e-05	9.81e-05	CcSEcCtD
Lenalidomide—Body temperature increased—Valproic Acid—epilepsy syndrome	2.8e-05	9.81e-05	CcSEcCtD
Lenalidomide—Anorexia—Gabapentin—epilepsy syndrome	2.8e-05	9.81e-05	CcSEcCtD
Lenalidomide—Anaemia—Topiramate—epilepsy syndrome	2.8e-05	9.8e-05	CcSEcCtD
Lenalidomide—PTGS2—Selenium Micronutrient Network—TNF—epilepsy syndrome	2.79e-05	0.000336	CbGpPWpGaD
Lenalidomide—Headache—Lamotrigine—epilepsy syndrome	2.79e-05	9.79e-05	CcSEcCtD
Lenalidomide—Decreased appetite—Pregabalin—epilepsy syndrome	2.78e-05	9.75e-05	CcSEcCtD
Lenalidomide—Agitation—Topiramate—epilepsy syndrome	2.78e-05	9.75e-05	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	2.76e-05	9.69e-05	CcSEcCtD
Lenalidomide—Fatigue—Pregabalin—epilepsy syndrome	2.76e-05	9.67e-05	CcSEcCtD
Lenalidomide—PTGS2—Disease—GBE1—epilepsy syndrome	2.76e-05	0.000332	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—PPP1R3C—epilepsy syndrome	2.76e-05	0.000332	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—CPSF4—epilepsy syndrome	2.76e-05	0.000332	CbGpPWpGaD
Lenalidomide—Hypotension—Gabapentin—epilepsy syndrome	2.74e-05	9.62e-05	CcSEcCtD
Lenalidomide—Nausea—Carbamazepine—epilepsy syndrome	2.74e-05	9.6e-05	CcSEcCtD
Lenalidomide—Constipation—Pregabalin—epilepsy syndrome	2.74e-05	9.6e-05	CcSEcCtD
Lenalidomide—Pain—Pregabalin—epilepsy syndrome	2.74e-05	9.6e-05	CcSEcCtD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	2.73e-05	0.000329	CbGpPWpGaD
Lenalidomide—Malaise—Topiramate—epilepsy syndrome	2.73e-05	9.57e-05	CcSEcCtD
Lenalidomide—Vertigo—Topiramate—epilepsy syndrome	2.72e-05	9.53e-05	CcSEcCtD
Lenalidomide—PTGS2—Metabolism—PFKL—epilepsy syndrome	2.71e-05	0.000327	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—SLCO1A2—epilepsy syndrome	2.71e-05	0.000327	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—SLC6A8—epilepsy syndrome	2.71e-05	0.000327	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—KCNB1—epilepsy syndrome	2.71e-05	0.000327	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CACNA2D2—epilepsy syndrome	2.71e-05	0.000327	CbGpPWpGaD
Lenalidomide—Syncope—Topiramate—epilepsy syndrome	2.71e-05	9.51e-05	CcSEcCtD
Lenalidomide—Leukopenia—Topiramate—epilepsy syndrome	2.71e-05	9.49e-05	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	2.67e-05	9.38e-05	CcSEcCtD
Lenalidomide—Palpitations—Topiramate—epilepsy syndrome	2.67e-05	9.37e-05	CcSEcCtD
Lenalidomide—Loss of consciousness—Topiramate—epilepsy syndrome	2.66e-05	9.32e-05	CcSEcCtD
Lenalidomide—Insomnia—Gabapentin—epilepsy syndrome	2.65e-05	9.31e-05	CcSEcCtD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	2.65e-05	0.000319	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	2.65e-05	0.000319	CbGpPWpGaD
Lenalidomide—Nausea—Lamotrigine—epilepsy syndrome	2.65e-05	9.28e-05	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—RELA—epilepsy syndrome	2.64e-05	0.000318	CbGpPWpGaD
Lenalidomide—Cough—Topiramate—epilepsy syndrome	2.64e-05	9.26e-05	CcSEcCtD
Lenalidomide—Feeling abnormal—Pregabalin—epilepsy syndrome	2.64e-05	9.25e-05	CcSEcCtD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	2.64e-05	0.000317	CbGpPWpGaD
Lenalidomide—Paraesthesia—Gabapentin—epilepsy syndrome	2.63e-05	9.24e-05	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2.62e-05	9.18e-05	CcSEcCtD
Lenalidomide—Dyspnoea—Gabapentin—epilepsy syndrome	2.62e-05	9.17e-05	CcSEcCtD
Lenalidomide—Hypertension—Topiramate—epilepsy syndrome	2.61e-05	9.16e-05	CcSEcCtD
Lenalidomide—Somnolence—Gabapentin—epilepsy syndrome	2.61e-05	9.15e-05	CcSEcCtD
Lenalidomide—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.61e-05	9.15e-05	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—MTOR—epilepsy syndrome	2.59e-05	0.000312	CbGpPWpGaD
Lenalidomide—Dyspepsia—Gabapentin—epilepsy syndrome	2.58e-05	9.06e-05	CcSEcCtD
Lenalidomide—Arthralgia—Topiramate—epilepsy syndrome	2.58e-05	9.03e-05	CcSEcCtD
Lenalidomide—Chest pain—Topiramate—epilepsy syndrome	2.58e-05	9.03e-05	CcSEcCtD
Lenalidomide—Myalgia—Topiramate—epilepsy syndrome	2.58e-05	9.03e-05	CcSEcCtD
Lenalidomide—Anxiety—Topiramate—epilepsy syndrome	2.57e-05	9e-05	CcSEcCtD
Lenalidomide—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	2.56e-05	8.97e-05	CcSEcCtD
Lenalidomide—Decreased appetite—Gabapentin—epilepsy syndrome	2.55e-05	8.95e-05	CcSEcCtD
Lenalidomide—Discomfort—Topiramate—epilepsy syndrome	2.54e-05	8.92e-05	CcSEcCtD
Lenalidomide—Urticaria—Pregabalin—epilepsy syndrome	2.54e-05	8.91e-05	CcSEcCtD
Lenalidomide—Asthenia—Valproic Acid—epilepsy syndrome	2.54e-05	8.91e-05	CcSEcCtD
Lenalidomide—ABCB1—Metabolism—CERS1—epilepsy syndrome	2.54e-05	0.000306	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—FAR1—epilepsy syndrome	2.54e-05	0.000306	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PDXK—epilepsy syndrome	2.54e-05	0.000306	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GLUD1—epilepsy syndrome	2.54e-05	0.000306	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—L2HGDH—epilepsy syndrome	2.54e-05	0.000306	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ADK—epilepsy syndrome	2.54e-05	0.000306	CbGpPWpGaD
Lenalidomide—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2.53e-05	8.88e-05	CcSEcCtD
Lenalidomide—Fatigue—Gabapentin—epilepsy syndrome	2.53e-05	8.87e-05	CcSEcCtD
Lenalidomide—Abdominal pain—Pregabalin—epilepsy syndrome	2.53e-05	8.87e-05	CcSEcCtD
Lenalidomide—Body temperature increased—Pregabalin—epilepsy syndrome	2.53e-05	8.87e-05	CcSEcCtD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	2.53e-05	0.000304	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—VEGFA—epilepsy syndrome	2.52e-05	0.000303	CbGpPWpGaD
Lenalidomide—Dry mouth—Topiramate—epilepsy syndrome	2.52e-05	8.83e-05	CcSEcCtD
Lenalidomide—Constipation—Gabapentin—epilepsy syndrome	2.51e-05	8.8e-05	CcSEcCtD
Lenalidomide—Pain—Gabapentin—epilepsy syndrome	2.51e-05	8.8e-05	CcSEcCtD
Lenalidomide—Pruritus—Valproic Acid—epilepsy syndrome	2.5e-05	8.78e-05	CcSEcCtD
Lenalidomide—Confusional state—Topiramate—epilepsy syndrome	2.49e-05	8.73e-05	CcSEcCtD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	2.49e-05	0.0003	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—NEU1—epilepsy syndrome	2.48e-05	0.000299	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—UPB1—epilepsy syndrome	2.48e-05	0.000299	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ATIC—epilepsy syndrome	2.48e-05	0.000299	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	2.47e-05	0.000297	CbGpPWpGaD
Lenalidomide—Oedema—Topiramate—epilepsy syndrome	2.47e-05	8.66e-05	CcSEcCtD
Lenalidomide—Infection—Topiramate—epilepsy syndrome	2.45e-05	8.6e-05	CcSEcCtD
Lenalidomide—Shock—Topiramate—epilepsy syndrome	2.43e-05	8.52e-05	CcSEcCtD
Lenalidomide—Diarrhoea—Valproic Acid—epilepsy syndrome	2.42e-05	8.49e-05	CcSEcCtD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	2.42e-05	0.000291	CbGpPWpGaD
Lenalidomide—Nervous system disorder—Topiramate—epilepsy syndrome	2.42e-05	8.49e-05	CcSEcCtD
Lenalidomide—Feeling abnormal—Gabapentin—epilepsy syndrome	2.42e-05	8.48e-05	CcSEcCtD
Lenalidomide—Thrombocytopenia—Topiramate—epilepsy syndrome	2.42e-05	8.48e-05	CcSEcCtD
Lenalidomide—Tachycardia—Topiramate—epilepsy syndrome	2.41e-05	8.45e-05	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Gabapentin—epilepsy syndrome	2.4e-05	8.41e-05	CcSEcCtD
Lenalidomide—Skin disorder—Topiramate—epilepsy syndrome	2.4e-05	8.41e-05	CcSEcCtD
Lenalidomide—PTGS2—Metabolism—HSD17B4—epilepsy syndrome	2.39e-05	0.000288	CbGpPWpGaD
Lenalidomide—Hyperhidrosis—Topiramate—epilepsy syndrome	2.39e-05	8.37e-05	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—CASP3—epilepsy syndrome	2.38e-05	0.000287	CbGpPWpGaD
Lenalidomide—Hypersensitivity—Pregabalin—epilepsy syndrome	2.36e-05	8.27e-05	CcSEcCtD
Lenalidomide—Anorexia—Topiramate—epilepsy syndrome	2.35e-05	8.25e-05	CcSEcCtD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	2.34e-05	0.000282	CbGpPWpGaD
Lenalidomide—Dizziness—Valproic Acid—epilepsy syndrome	2.34e-05	8.21e-05	CcSEcCtD
Lenalidomide—Urticaria—Gabapentin—epilepsy syndrome	2.33e-05	8.17e-05	CcSEcCtD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	2.33e-05	0.000281	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PNPO—epilepsy syndrome	2.32e-05	0.00028	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—NHLRC1—epilepsy syndrome	2.32e-05	0.00028	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—EPM2A—epilepsy syndrome	2.32e-05	0.00028	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GAMT—epilepsy syndrome	2.32e-05	0.00028	CbGpPWpGaD
Lenalidomide—Abdominal pain—Gabapentin—epilepsy syndrome	2.32e-05	8.13e-05	CcSEcCtD
Lenalidomide—Body temperature increased—Gabapentin—epilepsy syndrome	2.32e-05	8.13e-05	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—JUN—epilepsy syndrome	2.31e-05	0.000279	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GBE1—epilepsy syndrome	2.31e-05	0.000278	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PPP1R3C—epilepsy syndrome	2.31e-05	0.000278	CbGpPWpGaD
Lenalidomide—Hypotension—Topiramate—epilepsy syndrome	2.31e-05	8.09e-05	CcSEcCtD
Lenalidomide—Asthenia—Pregabalin—epilepsy syndrome	2.3e-05	8.05e-05	CcSEcCtD
Lenalidomide—PTGS2—Disease—ST3GAL3—epilepsy syndrome	2.29e-05	0.000276	CbGpPWpGaD
Lenalidomide—Pruritus—Pregabalin—epilepsy syndrome	2.26e-05	7.94e-05	CcSEcCtD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	2.26e-05	0.000272	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—MMP9—epilepsy syndrome	2.25e-05	0.000271	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	2.25e-05	0.000271	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	2.25e-05	0.000271	CbGpPWpGaD
Lenalidomide—Vomiting—Valproic Acid—epilepsy syndrome	2.25e-05	7.89e-05	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.25e-05	7.89e-05	CcSEcCtD
Lenalidomide—Insomnia—Topiramate—epilepsy syndrome	2.23e-05	7.83e-05	CcSEcCtD
Lenalidomide—Rash—Valproic Acid—epilepsy syndrome	2.23e-05	7.83e-05	CcSEcCtD
Lenalidomide—Dermatitis—Valproic Acid—epilepsy syndrome	2.23e-05	7.82e-05	CcSEcCtD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	2.22e-05	0.000267	CbGpPWpGaD
Lenalidomide—Headache—Valproic Acid—epilepsy syndrome	2.22e-05	7.78e-05	CcSEcCtD
Lenalidomide—Paraesthesia—Topiramate—epilepsy syndrome	2.22e-05	7.77e-05	CcSEcCtD
Lenalidomide—PTGS2—Spinal Cord Injury—TNF—epilepsy syndrome	2.21e-05	0.000266	CbGpPWpGaD
Lenalidomide—Dyspnoea—Topiramate—epilepsy syndrome	2.2e-05	7.72e-05	CcSEcCtD
Lenalidomide—Somnolence—Topiramate—epilepsy syndrome	2.19e-05	7.7e-05	CcSEcCtD
Lenalidomide—Diarrhoea—Pregabalin—epilepsy syndrome	2.19e-05	7.68e-05	CcSEcCtD
Lenalidomide—Dyspepsia—Topiramate—epilepsy syndrome	2.17e-05	7.62e-05	CcSEcCtD
Lenalidomide—PTGS2—Metabolism—ASAH1—epilepsy syndrome	2.17e-05	0.000261	CbGpPWpGaD
Lenalidomide—Hypersensitivity—Gabapentin—epilepsy syndrome	2.16e-05	7.58e-05	CcSEcCtD
Lenalidomide—ABCB1—Allograft Rejection—TNF—epilepsy syndrome	2.16e-05	0.00026	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—QDPR—epilepsy syndrome	2.16e-05	0.00026	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CA4—epilepsy syndrome	2.16e-05	0.00026	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	2.16e-05	0.00026	CbGpPWpGaD
Lenalidomide—Decreased appetite—Topiramate—epilepsy syndrome	2.15e-05	7.53e-05	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.13e-05	7.47e-05	CcSEcCtD
Lenalidomide—Fatigue—Topiramate—epilepsy syndrome	2.13e-05	7.46e-05	CcSEcCtD
Lenalidomide—Dizziness—Pregabalin—epilepsy syndrome	2.12e-05	7.42e-05	CcSEcCtD
Lenalidomide—Pain—Topiramate—epilepsy syndrome	2.11e-05	7.4e-05	CcSEcCtD
Lenalidomide—Constipation—Topiramate—epilepsy syndrome	2.11e-05	7.4e-05	CcSEcCtD
Lenalidomide—PTGS2—Metabolism—STXBP1—epilepsy syndrome	2.11e-05	0.000254	CbGpPWpGaD
Lenalidomide—Asthenia—Gabapentin—epilepsy syndrome	2.11e-05	7.38e-05	CcSEcCtD
Lenalidomide—Nausea—Valproic Acid—epilepsy syndrome	2.1e-05	7.37e-05	CcSEcCtD
Lenalidomide—Pruritus—Gabapentin—epilepsy syndrome	2.08e-05	7.28e-05	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—SRC—epilepsy syndrome	2.08e-05	0.00025	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	2.07e-05	0.000249	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—NT5E—epilepsy syndrome	2.06e-05	0.000248	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ALAD—epilepsy syndrome	2.06e-05	0.000248	CbGpPWpGaD
Lenalidomide—Vomiting—Pregabalin—epilepsy syndrome	2.03e-05	7.13e-05	CcSEcCtD
Lenalidomide—Feeling abnormal—Topiramate—epilepsy syndrome	2.03e-05	7.13e-05	CcSEcCtD
Lenalidomide—ABCB1—Metabolism—COX3—epilepsy syndrome	2.03e-05	0.000244	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—VEGFA—epilepsy syndrome	2.02e-05	0.000243	CbGpPWpGaD
Lenalidomide—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.02e-05	7.08e-05	CcSEcCtD
Lenalidomide—Rash—Pregabalin—epilepsy syndrome	2.02e-05	7.08e-05	CcSEcCtD
Lenalidomide—Dermatitis—Pregabalin—epilepsy syndrome	2.02e-05	7.07e-05	CcSEcCtD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	2.01e-05	0.000242	CbGpPWpGaD
Lenalidomide—Diarrhoea—Gabapentin—epilepsy syndrome	2.01e-05	7.04e-05	CcSEcCtD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	2.01e-05	0.000242	CbGpPWpGaD
Lenalidomide—Headache—Pregabalin—epilepsy syndrome	2e-05	7.03e-05	CcSEcCtD
Lenalidomide—PTGS2—Metabolism—ALDH7A1—epilepsy syndrome	1.96e-05	0.000236	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CACNA1A—epilepsy syndrome	1.96e-05	0.000236	CbGpPWpGaD
Lenalidomide—Urticaria—Topiramate—epilepsy syndrome	1.96e-05	6.88e-05	CcSEcCtD
Lenalidomide—Abdominal pain—Topiramate—epilepsy syndrome	1.95e-05	6.84e-05	CcSEcCtD
Lenalidomide—Body temperature increased—Topiramate—epilepsy syndrome	1.95e-05	6.84e-05	CcSEcCtD
Lenalidomide—Dizziness—Gabapentin—epilepsy syndrome	1.94e-05	6.8e-05	CcSEcCtD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	1.94e-05	0.000233	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—SLCO1A2—epilepsy syndrome	1.92e-05	0.000232	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—KCNB1—epilepsy syndrome	1.92e-05	0.000232	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CACNA2D2—epilepsy syndrome	1.92e-05	0.000232	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PFKL—epilepsy syndrome	1.92e-05	0.000232	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—SLC6A8—epilepsy syndrome	1.92e-05	0.000232	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ST3GAL3—epilepsy syndrome	1.92e-05	0.000231	CbGpPWpGaD
Lenalidomide—Nausea—Pregabalin—epilepsy syndrome	1.9e-05	6.67e-05	CcSEcCtD
Lenalidomide—PTGS2—Metabolism—ADSL—epilepsy syndrome	1.88e-05	0.000226	CbGpPWpGaD
Lenalidomide—Vomiting—Gabapentin—epilepsy syndrome	1.87e-05	6.54e-05	CcSEcCtD
Lenalidomide—ABCB1—HIF-1-alpha transcription factor network—AKT1—epilepsy syndrome	1.86e-05	0.000223	CbGpPWpGaD
Lenalidomide—Rash—Gabapentin—epilepsy syndrome	1.85e-05	6.49e-05	CcSEcCtD
Lenalidomide—Dermatitis—Gabapentin—epilepsy syndrome	1.85e-05	6.48e-05	CcSEcCtD
Lenalidomide—PTGS2—Metabolism—GLUL—epilepsy syndrome	1.85e-05	0.000222	CbGpPWpGaD
Lenalidomide—Headache—Gabapentin—epilepsy syndrome	1.84e-05	6.45e-05	CcSEcCtD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	1.84e-05	0.000221	CbGpPWpGaD
Lenalidomide—Hypersensitivity—Topiramate—epilepsy syndrome	1.82e-05	6.38e-05	CcSEcCtD
Lenalidomide—PTGS2—Metabolism—CACNA1D—epilepsy syndrome	1.81e-05	0.000218	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	1.8e-05	0.000217	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	1.79e-05	0.000215	CbGpPWpGaD
Lenalidomide—Asthenia—Topiramate—epilepsy syndrome	1.77e-05	6.21e-05	CcSEcCtD
Lenalidomide—ABCB1—Metabolism—NEU1—epilepsy syndrome	1.76e-05	0.000212	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ATIC—epilepsy syndrome	1.76e-05	0.000212	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—UPB1—epilepsy syndrome	1.76e-05	0.000212	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	1.75e-05	0.000211	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	1.75e-05	0.000211	CbGpPWpGaD
Lenalidomide—Pruritus—Topiramate—epilepsy syndrome	1.75e-05	6.12e-05	CcSEcCtD
Lenalidomide—Nausea—Gabapentin—epilepsy syndrome	1.74e-05	6.11e-05	CcSEcCtD
Lenalidomide—PTGS2—Metabolism—TXNRD1—epilepsy syndrome	1.69e-05	0.000204	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—HSD17B4—epilepsy syndrome	1.69e-05	0.000204	CbGpPWpGaD
Lenalidomide—Diarrhoea—Topiramate—epilepsy syndrome	1.69e-05	5.92e-05	CcSEcCtD
Lenalidomide—PTGS2—Disease—EIF2AK2—epilepsy syndrome	1.67e-05	0.000201	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	1.66e-05	0.0002	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—AQP1—epilepsy syndrome	1.64e-05	0.000198	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PPP1R3C—epilepsy syndrome	1.64e-05	0.000197	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GBE1—epilepsy syndrome	1.64e-05	0.000197	CbGpPWpGaD
Lenalidomide—Dizziness—Topiramate—epilepsy syndrome	1.63e-05	5.72e-05	CcSEcCtD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.58e-05	0.00019	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	1.58e-05	0.00019	CbGpPWpGaD
Lenalidomide—Vomiting—Topiramate—epilepsy syndrome	1.57e-05	5.5e-05	CcSEcCtD
Lenalidomide—Rash—Topiramate—epilepsy syndrome	1.56e-05	5.46e-05	CcSEcCtD
Lenalidomide—Dermatitis—Topiramate—epilepsy syndrome	1.56e-05	5.45e-05	CcSEcCtD
Lenalidomide—Headache—Topiramate—epilepsy syndrome	1.55e-05	5.42e-05	CcSEcCtD
Lenalidomide—PTGS2—Disease—PPIA—epilepsy syndrome	1.54e-05	0.000186	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ASAH1—epilepsy syndrome	1.54e-05	0.000185	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	1.52e-05	0.000183	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	1.5e-05	0.000181	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—STXBP1—epilepsy syndrome	1.5e-05	0.00018	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—KCNJ11—epilepsy syndrome	1.49e-05	0.000179	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CHRM3—epilepsy syndrome	1.49e-05	0.000179	CbGpPWpGaD
Lenalidomide—Nausea—Topiramate—epilepsy syndrome	1.47e-05	5.14e-05	CcSEcCtD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	1.47e-05	0.000176	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—NT5E—epilepsy syndrome	1.46e-05	0.000176	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ALAD—epilepsy syndrome	1.46e-05	0.000176	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.45e-05	0.000175	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	1.42e-05	0.000171	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	1.39e-05	0.000167	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	1.39e-05	0.000167	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.39e-05	0.000167	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	1.36e-05	0.000164	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.36e-05	0.000163	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ADSL—epilepsy syndrome	1.33e-05	0.000161	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GLUL—epilepsy syndrome	1.31e-05	0.000157	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—AKT1—epilepsy syndrome	1.29e-05	0.000155	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	1.28e-05	0.000155	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	1.28e-05	0.000154	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	1.24e-05	0.00015	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ABCG2—epilepsy syndrome	1.21e-05	0.000146	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	1.2e-05	0.000145	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.19e-05	0.000144	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.18e-05	0.000142	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CYP2C19—epilepsy syndrome	1.18e-05	0.000142	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CYP11A1—epilepsy syndrome	1.17e-05	0.000141	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.17e-05	0.00014	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—AQP1—epilepsy syndrome	1.17e-05	0.00014	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—SLC2A1—epilepsy syndrome	1.14e-05	0.000138	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—JUNB—epilepsy syndrome	1.14e-05	0.000137	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—NOS1—epilepsy syndrome	1.13e-05	0.000136	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	1.12e-05	0.000135	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—HBEGF—epilepsy syndrome	1.08e-05	0.00013	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	1.07e-05	0.000128	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.06e-05	0.000128	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CYP2D6—epilepsy syndrome	1.06e-05	0.000128	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—AKT3—epilepsy syndrome	1.06e-05	0.000127	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	1.05e-05	0.000127	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CHRM3—epilepsy syndrome	1.05e-05	0.000127	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—ADAM10—epilepsy syndrome	1.03e-05	0.000124	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ADRA2A—epilepsy syndrome	1.01e-05	0.000121	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—BCHE—epilepsy syndrome	1e-05	0.000121	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—CDC42—epilepsy syndrome	9.64e-06	0.000116	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—SLC2A1—epilepsy syndrome	9.58e-06	0.000115	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PLCB1—epilepsy syndrome	9.48e-06	0.000114	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—TH—epilepsy syndrome	9.45e-06	0.000114	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—HES1—epilepsy syndrome	8.82e-06	0.000106	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ABCG2—epilepsy syndrome	8.59e-06	0.000103	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—FYN—epilepsy syndrome	8.58e-06	0.000103	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—H2AFX—epilepsy syndrome	8.55e-06	0.000103	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	8.38e-06	0.000101	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	8.32e-06	0.0001	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—YWHAZ—epilepsy syndrome	8.25e-06	9.93e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	7.93e-06	9.55e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—CCR5—epilepsy syndrome	7.93e-06	9.55e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—HMOX1—epilepsy syndrome	7.88e-06	9.49e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CAT—epilepsy syndrome	7.78e-06	9.36e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ABCB1—epilepsy syndrome	7.57e-06	9.11e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	7.51e-06	9.04e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—TSC2—epilepsy syndrome	7.37e-06	8.88e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—APOE—epilepsy syndrome	7.22e-06	8.69e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	7.16e-06	8.62e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	7.15e-06	8.61e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—BCHE—epilepsy syndrome	7.12e-06	8.57e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GPX1—epilepsy syndrome	7.03e-06	8.47e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	6.79e-06	8.18e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—IL6ST—epilepsy syndrome	6.78e-06	8.16e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—NOS2—epilepsy syndrome	6.72e-06	8.1e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PLCB1—epilepsy syndrome	6.72e-06	8.09e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—TH—epilepsy syndrome	6.7e-06	8.06e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—AGT—epilepsy syndrome	6.17e-06	7.43e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—APOE—epilepsy syndrome	6.04e-06	7.28e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—HMOX1—epilepsy syndrome	5.59e-06	6.73e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CAT—epilepsy syndrome	5.51e-06	6.64e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—FGF2—epilepsy syndrome	5.48e-06	6.6e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—POMC—epilepsy syndrome	5.19e-06	6.25e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—MTOR—epilepsy syndrome	4.99e-06	6.01e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GPX1—epilepsy syndrome	4.99e-06	6e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ALB—epilepsy syndrome	4.73e-06	5.7e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—AGT—epilepsy syndrome	4.37e-06	5.26e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—APOE—epilepsy syndrome	4.28e-06	5.16e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—SRC—epilepsy syndrome	4e-06	4.81e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—POMC—epilepsy syndrome	3.68e-06	4.43e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ALB—epilepsy syndrome	3.36e-06	4.04e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PTGS2—epilepsy syndrome	2.94e-06	3.53e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—AKT1—epilepsy syndrome	2.49e-06	2.99e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—AKT1—epilepsy syndrome	2.08e-06	2.51e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—AKT1—epilepsy syndrome	1.48e-06	1.78e-05	CbGpPWpGaD
